Role of the clock gene Rev-erbα in metabolism and in the endocrine pancreas

Diabetes, Obesity and Metabolism

Volumn 17, Issue S1, 2015, Pages 106-114

  Vieira, E ^a   Merino, B ^b   Quesada, I ^b  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Clock genes; Glucose homeostasis; Insulin and glucagon secretion; Metabolism; Rev erb ; Type 2 diabetes

Indexed keywords

GLUCAGON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; GLUCOSE BLOOD LEVEL; NUCLEAR RECEPTOR NR1D1;

CIRCADIAN RHYTHM; GENE; GENE FUNCTION; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; METABOLIC REGULATION; METABOLISM; MOLECULAR CLOCK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOGENESIS; REV ERBALPHA GENE; REVIEW; ADIPOCYTE; FEEDBACK SYSTEM; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; MITOCHONDRION; PANCREAS ISLET; PHYSIOLOGY; SECRETION (PROCESS); SKELETAL MUSCLE; THERMOGENESIS;

ADIPOCYTES; BLOOD GLUCOSE; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEEDBACK, PHYSIOLOGICAL; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIPID METABOLISM; MITOCHONDRIA; MUSCLE, SKELETAL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; THERMOGENESIS;

EID: 84940551368     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12522     Document Type: Review

References (81)

1. Marroqui L, Alonso-Magdalena P, Merino B et al. Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes. Nutr Res Rev 2014; 27: 48-62.
2. Quesada I, Tuduri E, Ripoll C et al. Physiology of the pancreaticα-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol 2008; 199: 5-19.
3. Kahn SE, Zraika S, Utzschneider KM et al. The β cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009; 52: 1003-1012.
4. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 193-205.
5. Vieira E, Burris TP, Quesada I. Clock genes, pancreatic function, and diabetes. Trends Mol Med 2014; 20: 685-693.
6. Boden G, Ruiz J, Urbain JL et al. Evidence for a circadian rhythm of insulin secretion. Am J Physiol 1996; 271: E246-E252.
7. Kalsbeek A, Strubbe JH. Circadian control of insulin secretion is independent of the temporal distribution of feeding. Physiol Behav 1998; 63: 553-558.
8. Marcheva B, Ramsey KM, Peek CB et al. Circadian clocks and metabolism. Handb Exp Pharmacol 2013; 217: 127-155.
9. Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev 2009; 10(Suppl. 2): 37-45.
10. Di Lorenzo L, De Pergola G, Zocchetti C et al. Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obes Relat Metab Disord 2003; 27: 1353-1358.
11. Ellingsen T, Bener A, Gehani AA. Study of shift work and risk of coronary events. J R Soc Promot Health 2007; 127: 265-267.
12. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27, 485 people. Occup Environ Med 2001; 58: 747-752.
13. Knutsson A. Health disorders of shift workers. Occup Med 2003; 53: 103-108.
14. Leproult R, Holmback U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014; 63: 1860-1869.
15. Pan A, Schernhammer ES, Sun Q et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 2011; 8: e1001141.
16. Caciari T, Tomei G, De Sio S et al. Evaluation of some cardiovascular risk parameters in health professionals exposed to night work. Ann Ig 2013; 25: 23-30.
17. Scheer FA, Hilton MF, Mantzoros CS et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009; 106: 4453-4458.
18. Donga E, van Dijk M, van Dijk JG et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010; 95: 2963-2968.
19. Spiegel K, Knutson K, Leproult R et al. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005; 99: 2008-2019.
20. Taheri S, Lin L, Austin D et al. Short sleep duration is associated with reduced leptin, elevated Ghrelin, and increased body mass index. PLoS Med 2004; 1: e62.
21. Boden G, Chen X, Polansky M. Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes. Diabetes 1999; 48: 2182-2188.
22. Turek FW, Joshu C, Kohsaka A et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005; 308: 1043-1045.
23. Rudic RD, McNamara P, Curtis AM et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004; 2: e377.
24. Shimba S, Ishii N, Ohta Y et al. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci U S A 2005; 102: 12071-12076.
25. Marcheva B, Ramsey KM, Buhr ED et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010; 466: 627-631.
26. Grimaldi B, Bellet MM, Katada S et al. PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab 2010; 12: 509-520.
27. Barclay JL, Shostak A, Leliavski A et al. High-fat diet-induced hyperinsulinaemia and tissue-specific insulin resistance in Cry-deficient mice. Am J Physiol Endocrinol Metab 2013; 304: E1053-E1063.
28. Zhang EE, Liu Y, Dentin R et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med 2010; 16: 1152-1156.
29. Lau P, Fitzsimmons RL, Raichur S et al. The orphan nuclear receptor, ROR∝, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J Biol Chem 2008; 283: 18411-18421.
30. Le Martelot G, Claudel T, Gatfield D et al. REV-ERB∝ participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol 2009; 7: e1000181.
31. Preitner N, Damiola F, Lopez-Molina L et al. The orphan nuclear receptor REV-ERB∝ controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002; 110: 251-260.
32. Cho H, Zhao X, Hatori M et al. Regulation of circadian behaviour and metabolism by REV-ERB-∝ and REV-ERB-β. Nature 2012; 485: 123-127.
33. Raghuram S, Stayrook KR, Huang P et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERB∝ and REV-ERBβ. Nat Struct Mol Biol 2007; 14: 1207-1213.
34. Yin L, Wu N, Curtin JC et al. Rev-erb∝, a heme sensor that coordinates metabolic and circadian pathways. Science 2007; 318: 1786-1789.
35. Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 2006; 111: 327-345.
36. Everett LJ, Lazar MA. Nuclear receptor Rev-erb∝: up, down, and all around. Trends Endocrinol Metab 2014; 25: 586-592.
37. Guillaumond F, Dardente H, Giguere V et al. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005; 20: 391-403.
38. Yang X, Downes M, Yu RT et al. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006; 126: 801-810.
39. Duez H, van der Veen JN, Duhem C et al. Regulation of bile acid synthesis by the nuclear receptor Rev-erb∝. Gastroenterology 2008; 135: 689-698.
40. Raspe E, Duez H, Mansen A et al. Identification of Rev-erb∝ as a physiological repressor of apoC-III gene transcription. J Lipid Res 2002; 43: 2172-2179.
41. Feng D, Liu T, Sun Z et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011; 331: 1315-1319.
42. Gerhart-Hines Z, Feng D, Emmett MJ et al. The nuclear receptor Rev-erb∝ controls circadian thermogenic plasticity. Nature 2013; 503: 410-413.
43. Fontaine C, Dubois G, Duguay Y et al. The orphan nuclear receptor Rev-Erb∝ is a peroxisome proliferator-activated receptor (PPAR) γ target gene and promotes PPARγ-induced adipocyte differentiation. J Biol Chem 2003; 278: 37672-37680.
44. Garaulet M, Smith CE, Gomez-Abellan P et al. REV-ERB-∝ circadian gene variant associates with obesity in two independent populations: Mediterranean and North American. Mol Nutr Food Res 2014; 58: 821-829.
45. Goumidi L, Grechez A, Dumont J et al. Impact of REV-ERBα gene polymorphisms on obesity phenotypes in adult and adolescent samples. Int J Obes 2013; 37: 666-672.
46. Ruano EG, Canivell S, Vieira E. REV-ERBα polymorphism is associated with obesity in the Spanish obese male population. PLoS One 2014; 9: e104065.
47. Vieira E, Ruano EG, Figueroa AL et al. Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome. PLoS One 2014; 9: e111678.
48. Downes M, Carozzi AJ, Muscat GE. Constitutive expression of the orphan receptor, Rev-erbAα, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol Endocrinol 1995; 9: 1666-1678.
49. Woldt E, Sebti Y, Solt LA et al. Rev-erb-∝ modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med 2013; 19: 1039-1046.
50. Vieira E, Nilsson EC, Nerstedt A et al. Relationship between AMPK and the transcriptional balance of clock-related genes in skeletal muscle. Am J Physiol Endocrinol Metab 2008; 295: E1032-E1037.
51. Garcia-Roves PM, Osler ME, Holmstrom MH et al. Gain-of-function R225Q mutation in AMP-activated protein kinase γ3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem 2008; 283: 35724-35734.
52. Bugge A, Feng D, Everett LJ et al. Rev-erb∝ and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev 2012; 26: 657-667.
53. Jager J, O'Brien WT, Manlove J et al. Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erb∝. Mol Endocrinol 2014; 28: 490-498.
54. Chung S, Lee EJ, Yun S et al. Impact of circadian nuclear receptor REV-ERB∝ on midbrain dopamine production and mood regulation. Cell 2014; 157: 858-868.
55. Grant D, Yin L, Collins JL et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erb∝. ACS Chem Biol 2010; 5: 925-932.
56. Meng QJ, McMaster A, Beesley S et al. Ligand modulation of REV-ERB∝ function resets the peripheral circadian clock in a phasic manner. J Cell Sci 2008; 121: 3629-3635.
57. Shin Y, Noel R, Banerjee S et al. Small molecule tertiary amines as agonists of the nuclear hormone receptor Rev-erb∝. Bioorg Med Chem Lett 2012; 22: 4413-4417.
58. Solt LA, Wang Y, Banerjee S et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012; 485: 62-68.
59. Trump RP, Bresciani S, Cooper AW et al. Optimized chemical probes for REV-ERB∝. J Med Chem 2013; 56: 4729-4737.
60. Muhlbauer E, Wolgast S, Finckh U et al. Indication of circadian oscillations in the rat pancreas. FEBS Lett 2004; 564: 91-96.
61. Muhlbauer E, Gross E, Labucay K et al. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606: 61-71.
62. Pulimeno P, Mannic T, Sage D et al. Autonomous and self-sustained circadian oscillators displayed in human islet cells. Diabetologia 2013; 56: 497-507.
63. Vieira E, Marroqui L, Batista TM et al. The clock gene Rev-erb∝ regulates pancreatic β-cell function: modulation by leptin and high-fat diet. Endocrinology 2012; 153: 592-601.
64. Nishiyama K, Hirai K. The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells. PLoS One 2014; 9: e102073.
65. Kohsaka A, Laposky AD, Ramsey KM et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007; 6: 414-421.
66. Tang XD, Xu R, Reynolds MF et al. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 2003; 425: 531-535.
67. Guenthner CJ, Bickar D, Harrington ME. Heme reversibly damps PERIOD2 rhythms in mouse suprachiasmatic nucleus explants. Neuroscience 2009; 164: 832-841.
68. Ruiter M, La Fleur SE, van Heijningen C et al. The daily rhythm in plasma glucagon concentrations in the rat is modulated by the biological clock and by feeding behavior. Diabetes 2003; 52: 1709-1715.
69. Vieira E, Marroqui L, Figueroa AL et al. Involvement of the clock gene Rev-erbα in the regulation of glucagon secretion in pancreaticα-cells. PLoS One 2013; 8: e69939.
70. Hirota T, Okano T, Kokame K et al. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem 2002; 277: 44244-44251.
71. Lamia KA, Sachdeva UM, DiTacchio L et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009; 326: 437-440.
72. Leclerc I, Sun G, Morris C et al. AMP-activated protein kinase regulates glucagon secretion from mouse pancreaticα cells. Diabetologia 2011; 54: 125-134.
73. Asher G, Gatfield D, Stratmann M et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008; 134: 317-328.
74. Nakahata Y, Kaluzova M, Grimaldi B et al. The NAD + -dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134: 329-340.
75. Nakahata Y, Sahar S, Astarita G et al. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 2009; 324: 654-657.
76. Ramsey KM, Yoshino J, Brace CS et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009; 324: 651-654.
77. Canto C, Gerhart-Hines Z, Feige JN et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458: 1056-1060.
78. Fulco M, Cen Y, Zhao P et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008; 14: 661-673.
79. Um JH, Pendergast JS, Springer DA et al. AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. PLoS One 2011; 6: e18450.
80. Kojetin D, Wang Y, Kamenecka TM et al. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol 2010; 6: 131-134.
81. Ashcroft FM, Rorsman P. K(ATP) channels and islet hormone secretion: new insights and controversies. Nat Rev Endocrinol 2013; 9: 660-669.